Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors : Focus on 4-Anilinoquinazolines
The 4-anilinoquinazolines (gefitinib, erlotinib and lapatinib) are members of a class of potent and selective inhibitors of the human epidermal growth factor receptor (HER) family of tyrosine kinases that have been developed to treat patients with tumours with defined genetic alterations of the HER...
|Published in:||Clinical Pharmacokinetics, Vol. 50, No. 6 (2011), p. 371-403|
|Other Involved Persons:||; ; ;|
|QR Code:||Show QR Code|